Targeting the Keap1-Nrf2 Axis in COPD: Comparative analysis of electrophilic and peptide-based Nrf2 activators in airway and immune cells

dc.contributor.authorRoger Laparra, Inés
dc.contributor.authorEstornut Navarro, Cristina
dc.contributor.authorMontero, Paula
dc.contributor.authorAparici, Mónica
dc.contributor.authorPuig, Carlos
dc.contributor.authorDavis, Andre M.
dc.contributor.authorAlbericio, Fernando
dc.contributor.authorDiego, Alfredo de
dc.contributor.authorMilara, Javier
dc.contributor.authorCortijo, Julio
dc.date.accessioned2026-04-09T07:52:07Z
dc.date.available2026-04-09T07:52:07Z
dc.date.issued2026
dc.description.abstractChronic obstructive pulmonary disease (COPD) is characterized by sustained oxidative stress, inflammation, and epithelial damage. The transcription factor Nrf2 is a master regulator of antioxidant and cytoprotective defenses, and its dysregulation has been implicated in COPD pathogenesis.en
dc.description.filiationUEV
dc.description.impact4.7 Q1 JCR 2024
dc.description.impact1.197 Q1 SJR 2024
dc.description.impactNo data IDR 2024
dc.description.sponsorshipPID2020-114871RB-I00
dc.description.sponsorshipCIBERES (CB06/06/0027)
dc.description.sponsorshipInstituto de Salud Carlos III, PI20/01363
dc.description.sponsorshipPrometeo 2017/023/UV
dc.description.sponsorshipCIGE/2023/171
dc.identifier.citationRoger, I., Estornut, C., Montero, P., Aparici, M., Puig, C., Davis, A. M., Albericio, F., De Diego, A., Milara, J., & Cortijo, J. (2026). Targeting the Keap1-Nrf2 Axis in COPD: Comparative analysis of electrophilic and peptide-based Nrf2 activators in airway and immune cells. European Journal of Pharmacology, 1019, 178716. https://doi.org/10.1016/j.ejphar.2026.178716
dc.identifier.doi10.1016/j.ejphar.2026.178716
dc.identifier.issn0014-2999
dc.identifier.issn1879-0712
dc.identifier.urihttps://hdl.handle.net/11268/17015
dc.language.isoeng
dc.peerreviewedSi
dc.relation.publisherversionhttps://doi.org/10.1016/j.ejphar.2026.178716
dc.rights.accessRightsembargoed access
dc.subject.otherBiociencias
dc.subject.otherEnfermedad Pulmonar Obstructiva Crónica
dc.subject.otherActivación Neutrófila
dc.subject.otherSistema Inmunológico
dc.subject.sdgGoal 3: Ensure healthy lives and promote well-being for all at all ages
dc.subject.unescoInmunología
dc.subject.unescoAparato respiratorio
dc.subject.unescoInvestigación médica
dc.titleTargeting the Keap1-Nrf2 Axis in COPD: Comparative analysis of electrophilic and peptide-based Nrf2 activators in airway and immune cellsen
dc.typejournal article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Targeting the Keap1.pdf
Size:
439.52 KB
Format:
Adobe Portable Document Format